Personalized Medicine World Conference 2015

Kim Popovits

Kim Popovits has served as president and CEO of Genomic Health since 2009 and as president and chief operating officer since 2002. Prior to joining Genomic Health, Popovits served in various roles, most recently as senior vice president of marketing and sales, at Genentech, Inc. During her 15 years at Genentech, she led the successful commercialization of 14 new therapies, including Herceptin. Before joining Genentech, Popovits served as division manager for American Critical Care. In 2008, Popovits was named Woman of the Year by the Women Health Care Executives, and she has been named one of the Most Influential Women in the Bay Area by The San Francisco Business Times from 2006 to 2011. She holds a bachelor of arts in business from Michigan State University.

Kim Popovits

Building Evidence & Value Based Standards Needed to Guide Clinical Practice